New treatment options for cutaneous T-cell lymphomas

Article Properties
Cite
Ladická, Miriam. “New Treatment Options for Cutaneous T-Cell Lymphomas”. Onkologie, vol. 16, no. 4, 2022, pp. 206-11, https://doi.org/10.36290/xon.2022.039.
Ladická, M. (2022). New treatment options for cutaneous T-cell lymphomas. Onkologie, 16(4), 206-211. https://doi.org/10.36290/xon.2022.039
Ladická M. New treatment options for cutaneous T-cell lymphomas. Onkologie. 2022;16(4):206-11.
Refrences
Title Journal Journal Categories Citations Publication Date
Mogamulizumab Efficacy by Prior Systemic Therapy in Patients Previously Treated For Cutaneous T-Cell Lymphoma: a MAVORIC Study Post-Hoc Analysis. T-Cell Lymphoma Forum 2019
Mogamulizumab: new treatment option for advanced stages cutaneous T-cell lymphomas -mycosis fungoides and Sezary syndrome Onkologie 1 2021
What factors guide treatment selection in mycosis fungoides and Sezary syndrome?

 Hematology
  • Education: Education (General)
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
 5 2021
10.1016/S1470-2045(18)30379-6
Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management Dermatology and Therapy
  • Medicine: Dermatology
  • Medicine: Medicine (General)
  • Medicine: Dermatology
 18 2021